Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort-Reference-Cited by-同舟云学术

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort

Published:2020-11 Issue:11 Volume:22 Page:1803-1811
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Lakeman Inge M.M.,Rodríguez-Girondo Mar,Lee Andrew,Ruiter Rikje,Stricker Bruno H.,Wijnant Sara R.A.,Kavousi Maryam,Antoniou Antonis C.,Schmidt Marjanka K.,Uitterlinden André G.,van Rooij Jeroen,Devilee Peter^ORCID

Funder

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-020-0884-4.pdf

Reference29 articles.

1. Breast cancer diagnosis and death in the Netherlands: a changing burden;van der Waal;Eur J Public Health,2015

2. The benefits and harms of breast cancer screening: an independent review;Marmot;Lancet,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic scores and their applications in kidney disease;Nature Reviews Nephrology;2024-09-13

2. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors;Genetics in Medicine;2024-07

3. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families;The Breast;2024-06

4. Weighted metrics are required when evaluating the performance of prediction models in nested case–control studies;BMC Medical Research Methodology;2024-05-17

5. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction;2024-02-13